Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation. - Wikidata - awgldk - TriplyDB

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

http://www.wikidata.org/entity/Q34364876

about

Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy.TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.Intratumoral immunotherapy for melanoma.Therapeutic targeting of Toll-like receptors in cutaneous disorders.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.Pattern recognition receptors: immune targets to enhance cancer immunotherapy.In situ vaccination for the treatment of cancer.An Enzyme-Directed Imidazoquinoline for Cancer Immunotherapy.Strategies for designing synthetic immune agonists.Innate immune mediators in cancer: between defense and resistance.Tumor-associated macrophages: implications in cancer immunotherapy.Delivering safer immunotherapies for cancer.Anti-tumor Activity of Toll-Like Receptor 7 Agonists.Incidental regression of an advanced basal cell carcinoma after ipilimumab exposure for metastatic melanoma 3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine.Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma.Roles for Innate Immunity in Combination Immunotherapies.TLR Agonists as Adjuvants for Cancer Vaccines.Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ.Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

P2860

Q30274995-E0120884-F174-4021-B32E-27A013180C05 Q33598026-08263766-F494-4840-9C9C-BFF80222BA04 Q36692838-D95E0D16-5B25-4414-AC29-78DAB195BCCF Q37713832-BD057CCA-75B1-437D-A894-2F7938F6DF30 Q38518518-2F91E6E6-D93B-4E18-9D0F-444FF6B9E316 Q38550117-123FEB4C-4D85-4BCE-B9C9-C24939532D6C Q38657642-4F0824DE-720A-4762-9AC4-BAA33B5646AE Q38690773-E07D736D-C8FE-4B58-A4FB-E7016F33864F Q38727470-EEABDB51-2FBC-4F75-A348-BEFD84775776 Q38741706-BF598F5B-E113-40C6-B1BB-C2809CC7A0A3 Q38841677-30B8E00D-2DE3-4D49-BAFE-D4BC913AA3AE Q38991015-397DB94E-240D-4DD8-8FAB-EDAE933BDEB2 Q39148281-78FB7EEF-1A38-4C83-9D8A-08C82D51F598 Q39330984-59A10426-94A5-4077-B993-2AFC1612C75E Q39377049-EF15387F-5B0B-427E-82BB-D3076946ACF9 Q39559982-D7E7FCDF-A455-45D9-A636-C744DCF66732 Q39575305-3319E1CC-1988-4FF0-840F-1F06C53AF9E7 Q41503615-FBB3B9F5-FE88-469A-8A44-8D3C4B5D0C56 Q41996352-56649AF3-6E6F-41D0-A762-30C38666828B Q41997055-0323C588-D8AE-463A-B309-18F6465066E4 Q45854947-3E4910F7-667E-4425-A51B-CC692C3EDB80 Q46721978-93A44142-8AB0-475E-977C-D8D457DF05F2 Q47093975-83310024-E9B3-4340-AEEA-EBC5934EC443 Q47572823-60191BA0-1635-410A-8E7D-A213B8C6CFF3 Q56896166-CA76B61C-DEA0-477E-AB88-C0E6E869205B Q57817490-82F11DB6-8F49-45BB-B216-52D7D42ACDAD Q57826568-6BCD6580-34D2-4E56-96A4-1935D16DBBC4

P2860

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

http://www.wikidata.org/entity/Q34364876

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@ast

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@en

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@nl

type

label

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@ast

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@en

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@nl

prefLabel

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@ast

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@en

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@nl

P1433

Q34364876-857459C1-D0A7-4DEB-83B6-E86576BFBE4D

P1476

Q34364876-8DAFD388-AFB8-424B-9F7F-AE439AEF229B

P2093

Q34364876-0990BE77-8BE2-4871-AF33-2234C5432778

Q34364876-0DF6A2DB-7B32-4D1E-A7C1-1BDDD22BB9EA

Q34364876-129D24E7-3F08-408E-9BB7-4A295406C100

Q34364876-87F27D8B-85C6-4BB4-8749-8346F506FC7F

Q34364876-AAE9588A-33CD-43F4-8550-E4424F32D344

Q34364876-AE4057F3-65C7-4ED8-8D95-3E3DAF4B28AE

Q34364876-B6FFB30A-1566-4E05-950E-0E142F274CFB

P2860

Q34364876-04B503B2-E701-470E-90FC-2BEBE0F46B3C

Q34364876-0C5F6343-351C-4C20-97A7-357E006BF1D8

Q34364876-0CCEC1CC-861B-4C60-9D1C-6AE89ACE6E2B

Q34364876-169C1770-0B07-4BB8-BE52-F1CE72C32710

Q34364876-1A4AC482-ECEA-4409-AF5D-683D7B71E32C

Q34364876-1B01B73D-964A-4785-A002-5DC60D5C050B

Q34364876-1E64E404-AB8B-41C7-A039-D66460D69226

Q34364876-257A9741-0351-4FB4-AB59-BDFAA578403C

Q34364876-2E2077D4-1182-4A27-8ABB-DE1B39C04DFA

Q34364876-2EC8AF8F-6472-4323-805E-46CA82D2298B

P304

Q34364876-F4B35AE9-8AF7-4314-A11D-99D2C1288069

P31

Q34364876-4F4F6C45-6BFC-488D-834B-B9FE1441C5A6

P356

Q34364876-D8BE87E2-1FE7-47AA-BBF9-F2C0DA56908E

P407

Q34364876-F9B166C5-882B-441B-BFF2-8B637D34FD70

P433

Q34364876-CB32A1C1-7B57-4A60-87F0-12DD2B55554B

P478

Q34364876-8C4D05A8-4B50-4BB6-A62F-D111CEF77787

P50

Q34364876-919A8A03-B754-45B7-AB32-81E4A569EDF4

Q34364876-BF9C5574-AFFD-4AE3-A648-7E4AA11237C0

P577

Q34364876-11E0CBC9-4EF1-4389-AEF1-0D333CA81892

P5875

Q34364876-9ECE1D51-5419-4C23-A3E5-3D6AAD9B9051

P698

Q34364876-D60902A8-5E39-455F-8BC0-3C8B972167BD

P921

Q34364876-450FF995-DED4-4BA6-A38D-DD3441960FFF

P932

Q34364876-168AC81B-B073-49AA-8B57-70B065928340

P356

JIMMUNOL.1401160

P1433

Journal of Immunology

P1476

Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

@en

P2093

Jennifer A Wargo

http://www.w3.org/2001/XMLSchema#string

John P Vasilakos

http://www.w3.org/2001/XMLSchema#string

Manisha Singh

http://www.w3.org/2001/XMLSchema#string

Patrick Hwu

http://www.w3.org/2001/XMLSchema#string

Willem W Overwijk

http://www.w3.org/2001/XMLSchema#string

Xue-Fei Huang

http://www.w3.org/2001/XMLSchema#string

Zhimin Dai

http://www.w3.org/2001/XMLSchema#string

P2860

Functional role of type I and type II interferons in antiviral defense

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Macrophage-tumor cell interactions regulate the function of nitric oxide

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study

Macrophage regulation of tumor responses to anticancer therapies.

P304

4722-4731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1401160

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P50

Zachary A. Cooper

P577

2014-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266152292

http://www.w3.org/2001/XMLSchema#string

P698

25252955

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4201984

http://www.w3.org/2001/XMLSchema#string